JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Allegion (NYSE:ALLE) Stock

Allegion (NYSE:ALLE) had its price objective boosted by analysts at JPMorgan Chase & Co. from $170.00 to $183.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has a “neutral” rating on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 1.86% from the company’s previous close.

A number of other brokerages have also recently commented on ALLE. Mizuho set a $180.00 price objective on Allegion in a research note on Friday. Robert W. Baird set a $196.00 target price on Allegion in a research report on Friday. Weiss Ratings raised shares of Allegion from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Evercore restated an “outperform” rating and set a $180.00 price target on shares of Allegion in a research note on Tuesday, September 22nd. Finally, Bank of America upgraded shares of Allegion from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $164.00 to $200.00 in a report on Friday. Four analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Allegion currently has an average rating of “Moderate Buy” and a consensus target price of $173.56.

Allegion Trading Up 1.8%

ALLE stock traded up $3.14 during mid-day trading on Friday, reaching $179.66. The company’s stock had a trading volume of 493,879 shares, compared to its average volume of 1,095,139. The company has a market cap of $15.28 billion, a price-to-earnings ratio of 23.57, a price-to-earnings-growth ratio of 3.23 and a beta of 0.81. The business’s 50 day moving average price is $156.04 and its 200 day moving average price is $146.13. The company has a current ratio of 1.93, a quick ratio of 1.23 and a debt-to-equity ratio of 0.96. Allegion has a 12 month low of $125.00 and a 12 month high of $183.11.

Allegion (NYSE:ALLE) last posted its quarterly earnings results on Thursday, October 22nd. The scientific and technical instruments company reported $2.60 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.10. Allegion had a net margin of 15.36% and a return on equity of 35.41%. The business had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.14 billion. During the same period last year, the company posted $2.30 earnings per share. The business’s quarterly revenue was up 9.6% on a year-over-year basis. On average, equities research analysts predict that Allegion will post 8.94 EPS for the current year.

Insiders Place Their Bets

In other news, Director Steven Mizell acquired 170 shares of Allegion stock in a transaction on Friday, August 28th. The stock was acquired at an average cost of $158.28 per share, with a total value of $26,907.60. Following the transaction, the director owned 5,899 shares of the company’s stock, valued at approximately $933,693.72. This trade represents a 2.97% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Vincent Wenos sold 1,000 shares of the company’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $168.25, for a total transaction of $168,250.00. Following the completion of the sale, the senior vice president directly owned 12,096 shares of the company’s stock, valued at $2,035,152. The trade was a 7.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Allegion

A number of hedge funds and other institutional investors have recently modified their holdings of ALLE. Gibbs Wealth Management grew its stake in Allegion by 5.2% in the 3rd quarter. Gibbs Wealth Management now owns 3,515 shares of the scientific and technical instruments company’s stock valued at $541,000 after buying an additional 173 shares in the last quarter. Manchester Capital Management LLC raised its holdings in Allegion by 1,283.7% during the 3rd quarter. Manchester Capital Management LLC now owns 1,190 shares of the scientific and technical instruments company’s stock valued at $183,000 after acquiring an additional 1,104 shares during the period. Farmers & Merchants Investments Inc. lifted its position in shares of Allegion by 11,761.9% during the third quarter. Farmers & Merchants Investments Inc. now owns 7,473 shares of the scientific and technical instruments company’s stock worth $1,149,000 after acquiring an additional 7,410 shares in the last quarter. Sterling Capital Management LLC lifted its position in shares of Allegion by 442.8% during the third quarter. Sterling Capital Management LLC now owns 17,620 shares of the scientific and technical instruments company’s stock worth $2,709,000 after acquiring an additional 14,374 shares in the last quarter. Finally, Yousif Capital Management LLC lifted its position in shares of Allegion by 588.1% during the third quarter. Yousif Capital Management LLC now owns 66,771 shares of the scientific and technical instruments company’s stock worth $10,267,000 after acquiring an additional 57,068 shares in the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.

Key Stories Impacting Allegion

Here are the key news stories impacting Allegion this week:

• Positive Sentiment: Q3 results exceeded expectations: Allegion reported adjusted earnings of $2.60 per share, above the $2.50 consensus estimate, while revenue rose 9.6% year over year to $1.17 billion, surpassing expectations of $1.14 billion. Allegion Q3 earnings report
• Positive Sentiment: Management raised its outlook: Allegion now expects fiscal 2026 adjusted EPS of $9.05-$9.10, above the $8.96 consensus, and revenue of approximately $4.5 billion versus the $4.4 billion analyst estimate. The company also lifted its reported revenue-growth outlook to 9.5%-10.5%. Allegion raises 2026 guidance
• Positive Sentiment: Americas demand remains strong: Americas non-residential organic revenue grew at a low-double-digit rate, supported by continued momentum and margin expansion. This strength was the primary factor behind the improved outlook. Allegion long-term investor takeaways
• Positive Sentiment: Bank of America upgraded Allegion: The firm raised its rating from “neutral” to “buy” and increased its price target from $164 to $200, signaling greater confidence in the company’s earnings trajectory and valuation potential. Bank of America analyst recommendations
• Negative Sentiment: International performance remains a concern: Coverage of the earnings call indicated that growth was led by the Americas, while weaker international conditions continue to weigh on the overall business mix.

Allegion Company Profile

Allegion plc (NYSE:ALLE) is a global security products and solutions company focused on protecting people and property. Its portfolio includes mechanical and electronic locks, access control systems, door closers, exit devices, door controls, and commercial doors and frames.

The company serves commercial, institutional, industrial, and residential customers through well-known brands including Schlage, Von Duprin, LCN, Steelcraft, Briton, and aptiQ. Its offerings range from traditional hardware to connected and electronic access solutions designed for offices, schools, healthcare facilities, multifamily properties, and homes.

Allegion was established as an independent public company in 2013 following its separation from Ingersoll Rand.